Copying and distributing are prohibited without permission of the publisher.

Watermark

Temasek bags $793m from latest Celltrion sale

medical waste
By John Loh
23 Oct 2018

Temasek Holdings pocketed W902bn ($793m) from its second sell-down in South Korea’s Celltrion this year, after pricing it at the investor-friendly end of the range.

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free Trial
By John Loh
23 Oct 2018